Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Compartmental genomics in living cells revealed by single-cell nanobiopsy.

Actis P, Maalouf MM, Kim HJ, Lohith A, Vilozny B, Seger RA, Pourmand N.

ACS Nano. 2014 Jan 28;8(1):546-53. doi: 10.1021/nn405097u. Epub 2013 Dec 4.

2.

Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease.

Jiang Y, Cowley SA, Siler U, Melguizo D, Tilgner K, Browne C, Dewilton A, Przyborski S, Saretzki G, James WS, Seger RA, Reichenbach J, Lako M, Armstrong L.

Stem Cells. 2012 Apr;30(4):599-611. doi: 10.1002/stem.1053.

3.

Reversible cation response with a protein-modified nanopipette.

Vilozny B, Actis P, Seger RA, Vallmajo-Martin Q, Pourmand N.

Anal Chem. 2011 Aug 15;83(16):6121-6. doi: 10.1021/ac201322v. Epub 2011 Jul 22.

4.

Reversible thrombin detection by aptamer functionalized STING sensors.

Actis P, Rogers A, Nivala J, Vilozny B, Seger RA, Jejelowo O, Pourmand N.

Biosens Bioelectron. 2011 Jul 15;26(11):4503-7. doi: 10.1016/j.bios.2011.05.010. Epub 2011 May 12.

5.

Voltage-controlled metal binding on polyelectrolyte-functionalized nanopores.

Actis P, Vilozny B, Seger RA, Li X, Jejelowo O, Rinaudo M, Pourmand N.

Langmuir. 2011 May 17;27(10):6528-33. doi: 10.1021/la2005612. Epub 2011 Apr 21.

6.

Dynamic control of nanoprecipitation in a nanopipette.

Vilozny B, Actis P, Seger RA, Pourmand N.

ACS Nano. 2011 Apr 26;5(4):3191-7. doi: 10.1021/nn200320b. Epub 2011 Mar 22.

7.
8.

Advances in the diagnosis and treatment of chronic granulomatous disease.

Seger RA.

Curr Opin Hematol. 2011 Jan;18(1):36-41. doi: 10.1097/MOH.0b013e32834115e7. Review.

PMID:
21076296
9.

Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease.

Meissner F, Seger RA, Moshous D, Fischer A, Reichenbach J, Zychlinsky A.

Blood. 2010 Sep 2;116(9):1570-3. doi: 10.1182/blood-2010-01-264218. Epub 2010 May 21.

10.

Indications for hemopoietic stem cell transplantation.

Roifman CM, Fischer A, Notarangelo LD, de la Morena MT, Seger RA.

Immunol Allergy Clin North Am. 2010 May;30(2):261-2. doi: 10.1016/j.iac.2010.03.004.

PMID:
20493401
11.

Hematopoietic stem cell transplantation for chronic granulomatous disease.

Seger RA.

Immunol Allergy Clin North Am. 2010 May;30(2):195-208. doi: 10.1016/j.iac.2010.01.003. Review.

PMID:
20493396
12.

Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen.

Reichenbach J, Lopatin U, Mahlaoui N, Beovic B, Siler U, Zbinden R, Seger RA, Galmiche L, Brousse N, Kayal S, Güngör T, Blanche S, Holland SM.

Clin Infect Dis. 2009 Dec 1;49(11):1703-10. doi: 10.1086/647945.

13.

Restoration of NET formation by gene therapy in CGD controls aspergillosis.

Bianchi M, Hakkim A, Brinkmann V, Siler U, Seger RA, Zychlinsky A, Reichenbach J.

Blood. 2009 Sep 24;114(13):2619-22. doi: 10.1182/blood-2009-05-221606. Epub 2009 Jun 18.

14.

First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching.

Reichenbach J, Van de Velde H, De Rycke M, Staessen C, Platteau P, Baetens P, Güngör T, Ozsahin H, Scherer F, Siler U, Seger RA, Liebaers I.

Pediatrics. 2008 Sep;122(3):e778-82. doi: 10.1542/peds.2008-0123.

PMID:
18762514
15.

Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.

Renner ED, Rylaarsdam S, Anover-Sombke S, Rack AL, Reichenbach J, Carey JC, Zhu Q, Jansson AF, Barboza J, Schimke LF, Leppert MF, Getz MM, Seger RA, Hill HR, Belohradsky BH, Torgerson TR, Ochs HD.

J Allergy Clin Immunol. 2008 Jul;122(1):181-7. doi: 10.1016/j.jaci.2008.04.037.

16.

Modern management of chronic granulomatous disease.

Seger RA.

Br J Haematol. 2008 Feb;140(3):255-66. doi: 10.1111/j.1365-2141.2007.06880.x. Review.

PMID:
18217895
17.

Transient hemophagocytosis with deficient cellular cytotoxicity, monoclonal immunoglobulin M gammopathy, increased T-cell numbers, and hypomorphic NEMO mutation.

Pachlopnik Schmid JM, Junge SA, Hossle JP, Schneider EM, Roosnek E, Seger RA, Gungor T.

Pediatrics. 2006 May;117(5):e1049-56. Epub 2006 Apr 24.

PMID:
16636116
18.

Quality control of a national bone marrow donor registry: results of a pilot study and proposal for a standardized approach.

Tiercy JM, Stadelmann S, Chapuis B, Gratwohl A, Schanz U, Seger RA, Faveri GN, Kern M, Morell A, Schwabe R, Schneider P.

Bone Marrow Transplant. 2003 Sep;32(6):623-7.

PMID:
12953136
19.

Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium.

Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE, Saurenmann T, Michel BA, Seger RA, Gay S, Lauener RP.

Am J Pathol. 2003 Apr;162(4):1221-7.

20.

Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita.

Güngör T, Corbacioglu S, Storb R, Seger RA.

Bone Marrow Transplant. 2003 Mar;31(5):407-10.

PMID:
12634734
21.

Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.

Seger RA, Gungor T, Belohradsky BH, Blanche S, Bordigoni P, Di Bartolomeo P, Flood T, Landais P, Müller S, Ozsahin H, Passwell JH, Porta F, Slavin S, Wulffraat N, Zintl F, Nagler A, Cant A, Fischer A.

Blood. 2002 Dec 15;100(13):4344-50. Epub 2002 Aug 8. Review.

PMID:
12393596
22.

Gene therapy of hematopoietic stem cells: strategies for improvement.

Hossle JP, Seger RA, Steinhoff D.

News Physiol Sci. 2002 Jun;17:87-92. Review.

PMID:
12021377
23.

Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-D-glucose in children with chronic granulomatous disease.

Güngör T, Engel-Bicik I, Eich G, Willi UV, Nadal D, Hossle JP, Seger RA, Steinert HC.

Arch Dis Child. 2001 Oct;85(4):341-5.

24.

Acquired deficiency of von Willebrand factor-cleaving protease in a patient suffering from acute systemic lupus erythematosus.

Güngör T, Furlan M, Lämmle B, Kuhn F, Seger RA.

Rheumatology (Oxford). 2001 Aug;40(8):940-2. No abstract available.

PMID:
11511766
25.

Lentivirus-mediated gene transfer of gp91phox corrects chronic granulomatous disease (CGD) phenotype in human X-CGD cells.

Saulnier SO, Steinhoff D, Dinauer MC, Zufferey R, Trono D, Seger RA, Hossle JP.

J Gene Med. 2000 Sep-Oct;2(5):317-25.

PMID:
11045425
26.

Evaluation of a clinical algorithm involving serum eosinophil cationic protein for guiding the anti-inflammatory treatment of bronchial asthma in childhood.

Prehn A, Seger RA, Torresani T, Molinari L, Sennhauser FH.

Pediatr Allergy Immunol. 2000 May;11(2):87-94.

PMID:
10893010
27.

Chronic enteroviral meningo-encephalitis in X-linked agammaglobulinaemia: favourable response to anti-enteroviral treatment.

Schmugge M, Lauener R, Bossart W, Seger RA, Güngör T.

Eur J Pediatr. 1999 Dec;158(12):1010-1. No abstract available.

PMID:
10592085
28.

Shwachman-Diamond syndrome: early bone marrow transplantation in a high risk patient and new clues to pathogenesis.

Faber J, Lauener R, Wick F, Betts D, Filgueira L, Seger RA, Güngör T.

Eur J Pediatr. 1999 Dec;158(12):995-1000. Review.

PMID:
10592077
29.

The relationship of serum-eosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma.

Prehn A, Seger RA, Faber J, Torresani T, Molinari L, Gerber A, Sennhauser FH.

Pediatr Allergy Immunol. 1998 Nov;9(4):197-203.

PMID:
9920218
31.

Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.

Ozsahin H, von Planta M, Müller I, Steinert HC, Nadal D, Lauener R, Tuchschmid P, Willi UV, Ozsahin M, Crompton NE, Seger RA.

Blood. 1998 Oct 15;92(8):2719-24.

PMID:
9763555
32.

Blockade of acute grade IV skin and eye graft-versus-host disease by anti-interleukin-2 receptor monoclonal antibody in genoidentical bone marrow transplantation setting.

Ozşahin H, Tuchschmid P, Lauener R, Waldvogel K, Nadal D, Seger RA.

Turk J Pediatr. 1998 Apr-Jun;40(2):231-5.

PMID:
9677728
33.

Greater omentum flaps and granulocyte transfusions as combined therapy of liver abscess in chronic granulomatous disease.

von Planta M, Ozsahin H, Schroten H, Stauffer UG, Seger RA.

Eur J Pediatr Surg. 1997 Aug;7(4):234-6.

PMID:
9297520
35.

Adenosine deaminase deficiency in adults.

Ozsahin H, Arredondo-Vega FX, Santisteban I, Fuhrer H, Tuchschmid P, Jochum W, Aguzzi A, Lederman HM, Fleischman A, Winkelstein JA, Seger RA, Hershfield MS.

Blood. 1997 Apr 15;89(8):2849-55.

36.

RAG mutations in human B cell-negative SCID.

Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, Friedrich W, Seger RA, Hansen-Hagge TE, Desiderio S, Lieber MR, Bartram CR.

Science. 1996 Oct 4;274(5284):97-9.

PMID:
8810255
37.

Bone marrow transplantation in cartilage-hair hypoplasia: correction of the immunodeficiency but not of the chondrodysplasia.

Berthet F, Siegrist CA, Ozsahin H, Tuchschmid P, Eich G, Superti-Furga A, Seger RA.

Eur J Pediatr. 1996 Apr;155(4):286-90.

PMID:
8777921
38.

The Hoyeraal-Hreidarsson syndrome: don't forget the associated immunodeficiency.

Berthet F, Tuchschmid P, Boltshauser E, Seger RA.

Eur J Pediatr. 1995 Dec;154(12):998. No abstract available.

PMID:
8801113
39.

Atypical Kawasaki disease with peripheral gangrene and myocardial infarction: therapeutic implications.

von Planta M, Fasnacht M, Holm C, Fanconi S, Seger RA.

Eur J Pediatr. 1995 Oct;154(10):830-4.

PMID:
8529683
40.
41.

Persistent vacuoles in leukocytes: familial Jordans anomaly.

Ulukutlu L, Koç ON, Taşyürekli M, Cullu F, Tüzüner N, Ulutin ON, Oz F, Seger RA, Sağlamer L.

Acta Paediatr Jpn. 1995 Apr;37(2):177-81.

PMID:
7793251
42.

Recombinant human interferon-gamma in patients with chronic granulomatous disease--European follow up study.

Weening RS, Leitz GJ, Seger RA.

Eur J Pediatr. 1995 Apr;154(4):295-8.

PMID:
7607280
43.

Glomerulonephritis associated with chronic granulomatous disease and systemic lupus erythematosus.

Schmitt CP, Schärer K, Waldherr R, Seger RA, Debatin KM.

Nephrol Dial Transplant. 1995;10(6):891-5. No abstract available.

PMID:
7566626
44.

156Pro-->Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox.

Leusen JH, Bolscher BG, Hilarius PM, Weening RS, Kaulfersch W, Seger RA, Roos D, Verhoeven AJ.

J Exp Med. 1994 Dec 1;180(6):2329-34.

45.

A syndrome of primary combined immunodeficiency with microcephaly, cerebellar hypoplasia, growth failure and progressive pancytopenia.

Berthet F, Caduff R, Schaad UB, Roten H, Tuchschmid P, Boltshauser E, Seger RA.

Eur J Pediatr. 1994 May;153(5):333-8. Review.

PMID:
8033921
47.

Non-Hodgkin's lymphoma in four children infected with the human immunodeficiency virus. Association with Epstein-Barr Virus and treatment.

Nadal D, Caduff R, Frey E, Hassam S, Zimmermann DR, Seigneurin JM, Plüss HJ, Seger RA.

Cancer. 1994 Jan 1;73(1):224-30.

PMID:
8275430
48.

Treatment of chronic granulomatous disease.

Seger RA, Ezekowitz RA.

Immunodeficiency. 1994;5(2):113-30. Review. No abstract available.

PMID:
8032364
49.

[Lupus erythematosus discoid-like dermatosis in a carrier of septic granulomatosis].

Hafner J, Panizzon R, Bruckner-Tuderman L, Wüthrich B, Seger RA, Burg G.

Hautarzt. 1993 Jul;44(7):452-6. German.

PMID:
8365880
50.

Supplemental Content

Loading ...
Support Center